Integration of human pancreatic islet genomic data refines regulatory mechanisms at Type 2 Diabetes susceptibility loci
Abstract
Human genetic studies have emphasised the dominant contribution of pancreatic islet dysfunction to development of Type 2 Diabetes (T2D). However, limited annotation of the islet epigenome has constrained efforts to define the molecular mechanisms mediating the, largely regulatory, signals revealed by Genome-Wide Association Studies (GWAS). We characterised patterns of chromatin accessibility (ATAC-seq, n=17) and DNA methylation (whole-genome bisulphite sequencing, n=10) in human islets, generating high-resolution chromatin state maps through integration with established ChIP-seq marks. We found enrichment of GWAS signals for T2D and fasting glucose was concentrated in subsets of islet enhancers characterised by open chromatin and hypomethylation, with the former annotation predominant. At several loci (including CDC123, ADCY5, KLHDC5) the combination of fine-mapping genetic data and chromatin state enrichment maps, supplemented by allelic imbalance in chromatin accessibility pinpointed likely causal variants. The combination of increasingly-precise genetic and islet epigenomic information accelerates definition of causal mechanisms implicated in T2D pathogenesis.
Data availability
-
Islet open chromatin dataAvailable through controlled access at the EGA website (study accession no: EGAS00001002592).
-
Islet DNA methylation dataAvailable through controlled access at the EGA website (study accession no: EGAS00001002592).
-
Transcription profiling by high throughput sequencing of human and mouse pancreatic islet-cellsAvailable from Array Express (accession no: E-MTAB-1294).
-
Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variantsAvailable from NCBI GEO (accession no: GSE51312).
-
Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variantsAvailable from Array Express (accession no: E-MTAB-1919).
-
Integrative analysis of 111 reference human epigenomesAvailable from Epigenome Roadmap website.
-
Discovery and Fine-Mapping of Glycaemic and Obesity-Related Trait Loci Using High-Density ImputationAvailable from the Engage consortium website.
-
Transcript Expression Data from Human Islets Links Regulatory Signals from Genome-Wide Association Studies for Type 2 Diabetes and Glycemic Traits to Their Downstream EffectorsAvailable from the EGA website (study accession no: EGAS00001002592).
-
An Expanded Genome-Wide Association Study of Type 2 Diabetes in EuropeansAvailable from the Diagram Consortium website.
-
Whole-genome Bisulfite Sequencing of Human Pancreatic Islets Reveals Novel Differentially Methylated Regions in Type 2 Diabetes PathogenesisAvailable through links in the Supplementary Data information.
-
A high-resolution map of human evolutionary constraint using 29 mammalsAvailable through the institutional website.
Article and author information
Author details
Funding
Wellcome (90367)
- Matthias Thurner
- Jason M Torres
- Anna L Gloyn
- Mark I McCarthy
Wellcome (90532)
- Matthias Thurner
- Jason M Torres
- Anna L Gloyn
- Mark I McCarthy
Wellcome (106130)
- Matthias Thurner
- Jason M Torres
- Anna L Gloyn
- Mark I McCarthy
Wellcome (98381)
- Matthias Thurner
- Jason M Torres
- Anna L Gloyn
- Mark I McCarthy
Wellcome (095101/Z/10/Z)
- Matthias Thurner
- Jason M Torres
- Anna L Gloyn
- Mark I McCarthy
Wellcome (200837/Z/16/Z)
- Matthias Thurner
- Jason M Torres
- Anna L Gloyn
- Mark I McCarthy
Wellcome (099673/Z/12/Z)
- Matthias Thurner
- Jason M Torres
- Anna L Gloyn
- Mark I McCarthy
Novo Nordisk
- Martijn van de Bunt
Horizon 2020 Framework Programme (HEALTH-F4-2007-201413)
- Vibe Nylander
- Anna L Gloyn
Royal Society
- Stephan Beck
National Institute for Health Research
- Anna L Gloyn
- Mark I McCarthy
National Institutes of Health (U01-DK105535)
- Anna L Gloyn
- Mark I McCarthy
National Institutes of Health (U01-DK085545)
- Anna L Gloyn
- Mark I McCarthy
National Institutes of Health (R01-DK098032)
- Anna L Gloyn
- Mark I McCarthy
National Institutes of Health (R01-MH090941)
- Anna L Gloyn
- Mark I McCarthy
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Marcelo Nobrega, University of Chicago, United States
Ethics
Human subjects: The Human Research Ethics Board at the University of Alberta (Pro00001754), the University of Oxford's Oxford Tropical Research Ethics Committee (OxTREC Reference: 2-15), or the Oxfordshire Regional Ethics Committee B (REC reference: 09/H0605/2) approved the studies. All organ donors provided informed consent for use of pancreatic tissue in research.
Version history
- Received: September 13, 2017
- Accepted: February 6, 2018
- Accepted Manuscript published: February 7, 2018 (version 1)
- Version of Record published: February 27, 2018 (version 2)
Copyright
© 2018, Thurner et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 4,404
- Page views
-
- 647
- Downloads
-
- 77
- Citations
Article citation count generated by polling the highest count across the following sources: Scopus, Crossref, PubMed Central.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Genetics and Genomics
The ‘diabetic bone paradox’ suggested that type 2 diabetes (T2D) patients would have higher areal bone mineral density (BMD) but higher fracture risk than individuals without T2D. In this study, we found that the genetically predicted T2D was associated with higher BMD and lower risk of fracture in both weighted genetic risk score (wGRS) and two-sample Mendelian randomization (MR) analyses. We also identified ten genomic loci shared between T2D and fracture, with the top signal at SNP rs4580892 in the intron of gene RSPO3. And the higher expression in adipose subcutaneous and higher protein level in plasma of RSPO3 were associated with increased risk of T2D, but decreased risk of fracture. In the prospective study, T2D was observed to be associated with higher risk of fracture, but BMI mediated 30.2% of the protective effect. However, when stratified by the T2D-related risk factors for fracture, we observed that the effect of T2D on the risk of fracture decreased when the number of T2D-related risk factors decreased, and the association became non-significant if the T2D patients carried none of the risk factors. In conclusion, the genetically determined T2D might not be associated with higher risk of fracture. And the shared genetic architecture between T2D and fracture suggested a top signal around RSPO3 gene. The observed effect size of T2D on fracture risk decreased if the T2D-related risk factors could be eliminated. Therefore, it is important to manage the complications of T2D to prevent the risk of fracture.
-
- Genetics and Genomics
The color pattern of insects is one of the most diverse adaptive evolutionary phenotypes. However, the molecular regulation of this color pattern is not fully understood. In this study, we found that the transcription factor Bm-mamo is responsible for black dilute (bd) allele mutations in the silkworm. Bm-mamo belongs to the BTB zinc finger family and is orthologous to mamo in Drosophila melanogaster. This gene has a conserved function in gamete production in Drosophila and silkworms and has evolved a pleiotropic function in the regulation of color patterns in caterpillars. Using RNAi and clustered regularly interspaced short palindromic repeats (CRISPR) technology, we showed that Bm-mamo is a repressor of dark melanin patterns in the larval epidermis. Using in vitro binding assays and gene expression profiling in wild-type and mutant larvae, we also showed that Bm-mamo likely regulates the expression of related pigment synthesis and cuticular protein genes in a coordinated manner to mediate its role in color pattern formation. This mechanism is consistent with the dual role of this transcription factor in regulating both the structure and shape of the cuticle and the pigments that are embedded within it. This study provides new insight into the regulation of color patterns as well as into the construction of more complex epidermal features in some insects.